Cloning and characterization of the antiviral activity of feline Tetherin/BST-2

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Fukuma, Aiko ^a,b,c   Abe, Masumi ^b   Morikawa, Yuko ^c   Miyazawa, Takayuki ^d   Yasuda, Jiro ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD 317; COMPLEMENTARY DNA; DNA FRAGMENT; FELINE HOMOLOG; FELINE TETHERIN; INTERFERON; MESSENGER RNA; PROTEIN RD 114; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPU PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; MEMBRANE PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; EXTRACELLULAR SPACE; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SWINE; VIRUS INFECTION; VIRUS INHIBITION; VIRUS RELEASE; ANIMAL; CAT; CELL STRAIN HEK293; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENDOGENOUS RETROVIRUS; GENETICS; METABOLISM; MOLECULAR GENETICS; VIRION;

FELIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CATS; CLONING, MOLECULAR; ENDOGENOUS RETROVIRUSES; GLYCOSYLATION; HEK293 CELLS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; INTERFERONS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, PROTEIN; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRION;

EID: 79953202160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018247     Document Type: Article

References (32)

1. Neil SJD, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-U421.
2. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, et al. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83: 1837-1844.
3. Mattiuzzo G, Ivol S, Takeuchi Y, (2010) Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J Virol 84: 2618-22.
4. Göttlinger HG, Dorfman T, Cohen EA, Haseltine WA, (1993) Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci USA 90: 7381-7385.
5. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P, (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci USA 106: 2886-2891.
6. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J, (2009) Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83: 2382-2385.
7. Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, et al. (2009) Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83: 9672-9681.
8. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, et al. (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709.
9. Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, et al. (1999) Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 258: 583-591.
10. Andrew AJ, Miyagi E, Kao S, Strebel K, (2009) The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology. 6: 80.
11. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511.
12. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, et al. (2006) Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177: 3260-3265.
13. Ishikawa J, Kaisho T, Tomizawa H, Lee BO, Kobune Y, et al. (1995) Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26: 527-534.
14. Le Tortorec A, Neil SJD, (2009) Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 83: 11966-11978.
15. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. (2009) Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6: 54-67.
16. Sauter D, Schindler M, Specht A, Landford WN, Münch J, et al. (2009) Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6: 409-421.
17. Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, et al. (2010) The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog 6: e1000913.
18. Reeves RH, Nash WG, O'Brien SJ, (1985) Genetic mapping of endogenous RD-114 retroviral sequences of domestic cats. J Virol 56: 303-306.
19. Baumann JG, Gunzburg WH, Salmons B, (1998) CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors. J Virol 72: 7685-7687.
20. Yoshikawa R, Sato E, Igarashi T, Miyazawa T, (2010) Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. J Clin Microbiol 48: 3366-3369.
21. Miyazawa T, Yoshikawa R, Golder M, Okada M, Stewart H, et al. (2010) Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. J Viol 84: 3690-3694.
22. Dunn KJ, Yuan CC, Blair DG, (1993) A phenotypic host range alteration determines RD114 virus restriction in feline embryonic cells. J Virol 67: 4704-4711.
23. Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J, (2006) Cellular factors required for Lassa virus budding. J Virol 80: 4191-4195.
24. Sakuma T, Sakurai A, Yasuda J, (2009) Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses. PLoS ONE 4: e6934.
25. Yasuda J, Hunter E, (1998) A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol 72: 4095-4103.
26. Sakaguchi S, Okada M, Shojima T, Baba K, Miyazawa T, (2008) Establishment of a LacZ marker rescue assay to detect infectious RD114 virus. J Vet Med Sci 70: 785-790.
27. Rollason R, Korolchuk V, Hamilton C, Schu P, Banting G, (2007) Clathrinmediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120: 3850-3858.
28. Masuyama N, Kuronita T, Tanaka R, Muto T, Hirota Y, et al. (2009) HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J Biol Chem 284: 15927-15941.
29. Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, et al. (2009) Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog 5: e1000443.
30. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. (2009) Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5: e1000300.
31. Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, et al. (2009) The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol 83: 7536-7546.
32. Tokarev AA, Munguia J, Guatelli JC, (2010) Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J Virol 85: 51-63.